Comprehensive Whole‐Course Management Strategy for Recurrent Renal Cell Carcinoma: Case Report and Literature Review
ABSTRACT Renal cell carcinoma, a highly recurrent and metastatic malignancy. Drawing upon a decade‐long expertise in managing recurrent cases, we advocate the adoption of Programmed Death‐1 (PD‐1) inhibitors in conjunction with Axitinib when monotherapy with Axitinib fails to restrain tumor metastas...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.70418 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849718661977210880 |
|---|---|
| author | PengNan Hu Di Chen Jun Yu Hua Mi |
| author_facet | PengNan Hu Di Chen Jun Yu Hua Mi |
| author_sort | PengNan Hu |
| collection | DOAJ |
| description | ABSTRACT Renal cell carcinoma, a highly recurrent and metastatic malignancy. Drawing upon a decade‐long expertise in managing recurrent cases, we advocate the adoption of Programmed Death‐1 (PD‐1) inhibitors in conjunction with Axitinib when monotherapy with Axitinib fails to restrain tumor metastasis, thereby empowering doctors with an efficacious treatment option. |
| format | Article |
| id | doaj-art-e6de4396257249d79eabfac9f27ce3eb |
| institution | DOAJ |
| issn | 2050-0904 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj-art-e6de4396257249d79eabfac9f27ce3eb2025-08-20T03:12:19ZengWileyClinical Case Reports2050-09042025-05-01135n/an/a10.1002/ccr3.70418Comprehensive Whole‐Course Management Strategy for Recurrent Renal Cell Carcinoma: Case Report and Literature ReviewPengNan Hu0Di Chen1Jun Yu2Hua Mi3Department of Urology The First Affiliated Hospital of Guangxi Medical University Nanning ChinaDepartment of Urology The First Affiliated Hospital of Guangxi Medical University Nanning ChinaDepartment of Urology The First Affiliated Hospital of Guangxi Medical University Nanning ChinaDepartment of Urology The First Affiliated Hospital of Guangxi Medical University Nanning ChinaABSTRACT Renal cell carcinoma, a highly recurrent and metastatic malignancy. Drawing upon a decade‐long expertise in managing recurrent cases, we advocate the adoption of Programmed Death‐1 (PD‐1) inhibitors in conjunction with Axitinib when monotherapy with Axitinib fails to restrain tumor metastasis, thereby empowering doctors with an efficacious treatment option.https://doi.org/10.1002/ccr3.70418comprehensive whole‐course managementimmunotherapymolecular targeted therapyNivolumabrecurrent renal cell carcinoma |
| spellingShingle | PengNan Hu Di Chen Jun Yu Hua Mi Comprehensive Whole‐Course Management Strategy for Recurrent Renal Cell Carcinoma: Case Report and Literature Review Clinical Case Reports comprehensive whole‐course management immunotherapy molecular targeted therapy Nivolumab recurrent renal cell carcinoma |
| title | Comprehensive Whole‐Course Management Strategy for Recurrent Renal Cell Carcinoma: Case Report and Literature Review |
| title_full | Comprehensive Whole‐Course Management Strategy for Recurrent Renal Cell Carcinoma: Case Report and Literature Review |
| title_fullStr | Comprehensive Whole‐Course Management Strategy for Recurrent Renal Cell Carcinoma: Case Report and Literature Review |
| title_full_unstemmed | Comprehensive Whole‐Course Management Strategy for Recurrent Renal Cell Carcinoma: Case Report and Literature Review |
| title_short | Comprehensive Whole‐Course Management Strategy for Recurrent Renal Cell Carcinoma: Case Report and Literature Review |
| title_sort | comprehensive whole course management strategy for recurrent renal cell carcinoma case report and literature review |
| topic | comprehensive whole‐course management immunotherapy molecular targeted therapy Nivolumab recurrent renal cell carcinoma |
| url | https://doi.org/10.1002/ccr3.70418 |
| work_keys_str_mv | AT pengnanhu comprehensivewholecoursemanagementstrategyforrecurrentrenalcellcarcinomacasereportandliteraturereview AT dichen comprehensivewholecoursemanagementstrategyforrecurrentrenalcellcarcinomacasereportandliteraturereview AT junyu comprehensivewholecoursemanagementstrategyforrecurrentrenalcellcarcinomacasereportandliteraturereview AT huami comprehensivewholecoursemanagementstrategyforrecurrentrenalcellcarcinomacasereportandliteraturereview |